SCHEDULE 13G/A: Alyeska Investment Group Discloses Passive 2.1% Stake in Verastem, Inc.

Alyeska Investment Group, L.P., along with its affiliates, reported a passive beneficial ownership of 2.1% of Verastem, Inc.'s common stock as of December 31, 2024.

Summary

• Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh collectively filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Verastem, Inc.
• As of December 31, 2024, the reporting persons beneficially owned an aggregate of 1,000,000 shares of Verastem, Inc. common stock.
• This ownership represents 2.1% of the total outstanding common stock of Verastem, Inc.
• The calculation of the percentage of class is based on 44,506,526 outstanding shares, as reported in Verastem, Inc.'s Quarterly Report Form 10-Q filed on November 6, 2024.
• The reporting persons hold shared voting power and shared dispositive power over all 1,000,000 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a standard beneficial ownership disclosure (Schedule 13G) indicating a passive stake, which is neutral in sentiment as it does not convey positive or negative operational or financial performance.

Future Outlook

NA

Management Comments

• The reporting persons certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

This filing is a standard disclosure of passive beneficial ownership by an institutional investor in a publicly traded company. It does not provide broader industry trends or context.

Key Dates

Keywords

Verastem Inc., Alyeska Investment Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor